BioProcess International Conference & Exposition

BPI Is Engineered to Be Exactly What You Need It to Be…

Save $400 by July 17

Conference: October 26-29, 2015 * Exposition:  October 27-29, 2015 * John B Hynes Veterans Memorial Convention Center, Boston, MA

navigation

THE Industry Meeting Place to Exchange Real-World Solutions to Improve Speed, Cost and Quality

Conference: October 26-29, 2015 · Exhibition: October 17-19, 2015 · John B Hynes Veterans Memorial Convention Center · Boston, MA

Scientific Advisory Board

Scientific Advisory Board

BPI 2015 Scientific Advisory Board

Cell Culture & Upstream Processing

Susan Dana Jones, Ph.D., Vice President and Senior Consultant, BioProcess Technology Consultants

Thomas Jostock, Ph.D., New Technologies Network Leader/Novartis Leading Scientist, Novartis, Switzerland

John Moscariello, Ph.D., Vice President, Process Development, CMC Biologics

Alison Porter, Ph.D., Head of Mammalian Cell Culture, R&D, Fujifilm Diosynth Biotechnologies

Charles Sardonini, Ph.D., Director, Process Engineering/Development, Genzyme, a Sanofi Company

Recovery & Purification

Hanne Bak, Ph.D., Senior Director, Purification Development, Regeneron Pharmaceuticals, Inc.

Pete Gagnon, M.S., Head of Downstream Processing, Bioprocessing Technology Institute, Singapore

Uwe Gottschalk, Ph.D., Chief Technology Officer, Pharma Biotech, Lonza, Switzerland

Günter Jagschies, Ph.D., Senior Director, Strategic Customer Relations, Biotechnologies R&D, GE Healthcare Life Sciences, Sweden

Ken Kang, Ph.D., Principal Scientist, Head of Purification R&D, BioProcess Sciences, Eli Lilly and Company

Joseph Martin, Ph.D., Research Fellow, Pfizer, Inc.

James Patch, Ph.D., Senior Engineer, Purification Development, Genentech

Natraj Ram, Ph.D., Associate Director, Purification, Manufacturing Sciences, AbbVie Bioresearch Center

Thomas Ransohoff, Vice President and Senior Consultant, BioProcess Technology Consultants, Inc.

Gregory Zarbis-Papastoitsis, Ph.D., VP of Process and Manufacturing Sciences, Eleven Biotherapeutics

Frank Riske, Ph.D., Consultant, Purification, BioProcess Technology Consultants and Formerly of Genzyme

Analytical, Formulation & Quality

Mark Moody, Ph.D., Biopharma Consultant and Former Vice President, Analytical Sciences, Merrimack Pharmaceuticals

Melissa Morandi, Vice President, Global Quality, Aegerion Pharmaceuticals

Thomas Porter, Ph.D., Senior Director, Analytical R&D, Global Biologics, Pfizer, Inc.

Manasi Puri, Scientist, Biopharmaceutical Technologies, GlaxoSmithKline

Nadine Ritter, Ph.D., President and Analytical Advisor, Global Biotech Experts, LLC

Arvind Srivastava, Ph.D., Director, Formulation Development, ImClone Systems

Johnson Varghese, Ph.D., Senior Director/Head, Analytical Development, Shire

Manufacturing Strategy

Chris Antoniou, MS, Distinguished Engineer, Global Engineering Science, Biogen Idec Inc

Barak Barnoon, Director Process Engineering & Analytics, Pfizer Global Engineering, Pfizer

Kenneth Green, Ph.D., Head of Manufacturing Science and Technology, Shire

Nathalie Hayduk, Strategic Portfolio Leader, Biosciences Manufacturing Group, Pfizer Inc.

Deborah Meshulam, M.S., Director, Contract Manufacturing, ImmunoGen, Inc.

David Pollard, Ph.D., Executive Director, BioProcess Technology & Expression, Merck & Co., Inc.

Stephanie Rieder, Ph.D., Senior Scientist III, Global Biologics Department, AbbVie

Jonathan Romero, Ph.D., Associate Director, Operations, Technology, Innovation, Global Engineering, Biogen Idec

Rick St. John, Ph.D., Senior Group Leader, Purification Development, Genentech, Inc.

Ran Zheng, Executive Director, Plant Manager, Amgen Inc.

Drug Product Manufacturing & Fill-Finish Processing

Suketu Desai, Ph.D., Vice President, Biologics Development, Drug Substance and Drug Product R&D, Allergan, Inc.

Kevin Kerls, Senior Manager, Genentech, Inc. - A Member of the Roche Group

Kevin Maloney, Ph.D., Principal Scientist, Technical Development, Biogen

General

Sid Advant, President, Kemwell Biopharma

Joanne Beck, Ph.D., Vice President, Process Development, Shire Human Genetic Therapies

Susan Dexter, Senior Principal Consultant, Latham BioPharm Group

Susan Dana Jones, Ph.D., Vice President and Senior Consultant, BioProcess Technology Consultants

Peter Latham, President, Latham BioPharm Group

Thomas Ransohoff, Vice President and Senior Consultant, BioProcess Technology Consultants, Inc.

Robert Repetto, M.S., MBA, Senior Director, External Affairs, Pfizer

Frank Riske, Ph.D., Consultant, Purification, BioProcess Technology Consultants and Formerly of Genzyme

Charles Sardonini, Ph.D., Director, Process Engineering/Development, Genzyme, a Sanofi Company

Ian Sellick, Director of Marketing, Pall Life Sciences

Gregory Zarbis-Papastoitsis, Ph.D., VP of Process and Manufacturing Sciences, Eleven Biotherapeutics

Charles River
BPI China

footer

BounceX